BioAtla (BCAB) Other financing activities (2020 - 2026)
BioAtla (BCAB) posted quarterly Other financing activities of $289000.0 for Q1 2026, down 21.04% year-over-year from $366000.0 in Q1 2025, and up 445.28% quarter-over-quarter from $53000.0 in Q4 2025.
BioAtla (BCAB) Other financing activities (2020 - 2026) Analysis & Trends
BioAtla's Other financing activities history runs 7 years deep, the most recent figure standing at $289000.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 21.04% year-over-year to $289000.0; the TTM figure through Mar 2026 stood at $23000.0 (down 96.75% YoY), while the FY2025 annual figure was $100000.0, down 70.76% from the prior year.
- Other financing activities for Q1 2026 stood at $289000.0, up from $53000.0 in the prior quarter.
- The five-year high for Other financing activities was $366000.0 in Q1 2025, with the low at -$397000.0 in Q3 2025.
- The 5-year median for Other financing activities is $149000.0 (2023), against an average of $105818.2.
- Peak annual rise in Other financing activities reached 129.53% in 2024, while the deepest fall reached 1842.86% in 2024.
- BioAtla's Other financing activities stood at $270000.0 in 2022, then plunged by 44.81% to $149000.0 in 2023, then jumped by 129.53% to $342000.0 in 2024, then sank by 84.5% to $53000.0 in 2025, then soared by 445.28% to $289000.0 in 2026.
- Business Quant data shows BCAB's Other financing activities at $289000.0 in Q1 2026, $53000.0 in Q4 2025, and -$397000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - |
| 10 | BioAtla | 5.23 Mn | 5.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 289,000.00 |
| Mar 31, 2026 | 289,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | -397,000.00 |
| Sep 30, 2025 | -397,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 342,000.00 |
| Dec 31, 2024 | 342,000.00 |
| Sep 30, 2024 | -244,000.00 |
| Sep 30, 2024 | -244,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Jun 30, 2024 | 244,000.00 |
| Dec 31, 2023 | 149,000.00 |
| Dec 31, 2023 | 149,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |